REVITALIST LIFESTYLE WLNS - RVLWF STOCK NEWS

Revitalist Lifestyle and Wellness (CSE: CALM) (OTC: RVLWF) has partnered with Wake Network to launch Lion's Brain, a proprietary supplement line designed to enhance mental clarity and wellbeing. The product combines brain-healthy organic multivitamins with organic functional mushrooms, including B Vitamins, Magnesium, Cordyceps, Lion's Mane, Reishi, Chaga, and Ashwagandha. This collaboration aims to offer a natural, holistic solution for symptoms of depression, anxiety, fatigue, and attention deficit disorders.

The supplements will be available in Revitalist clinics, online at revitalist.com, Wakewell.net, and Amazon.com. This partnership leverages Wake Network's expertise in eco-conscious packaging and distribution, while Revitalist focuses on delivering superior wellness products to empower individuals in managing their mental health.

Revitalist Lifestyle and Wellness (CSE: CALM) (OTC: RVLWF) is sponsoring The American Legion's 105th National Convention from August 23-29, 2024. The event focuses on addressing veteran suicides through the 'Be the One' campaign. Revitalist will offer free ketamine and psychedelic consultations, give away two psychedelic retreats, and donate 100% of their sales to veterans needing ketamine and psychedelic therapies.

CEO Kathryn A. Walker and her team will provide wellness services on-site, with all proceeds supporting veteran treatments. The company is also extending support online, donating all supplement and book purchases made through their website during the convention period to veteran treatment.

Revitalist Lifestyle and Wellness CEO Kathryn A. Walker is set to speak at the American Association of Nurse Anesthesiologists (AANA) Annual Congress on August 5, 2024, in San Diego. Her presentation, titled 'Entering the World of Psychedelics as an Anesthesia Professional,' will explore the emerging field of psychedelic medicines and their relevance to nurse anesthetists.

The session will cover key topics including:

• Identification of psychedelic medicines and their legal approval status
• Pharmacologic nature of psychedelic medications and their applications
• Guidelines for working in the outpatient community

Walker emphasizes the transformative potential of psychotropic medications in healthcare, particularly for mental health and complex conditions management. The presentation aims to provide valuable insights for CRNAs looking to contribute to this evolving field.

Revitalist Lifestyle and Wellness (CSE: CALM) announces the presale of CEO Kathryn A. Walker's new book, 'Inflamed: Theory', available on Kindle and Amazon. The book explores innovative approaches to mental health and psychedelic therapies, challenging traditional theories. Walker, a nurse anesthetist and psychiatric nurse practitioner, examines the relationship between mental health and neurological processes in the brain.

Key topics include:

• The impact of psychedelics on mental health
• Newtonian framework of mental health and conflict
• Cognitive dynamics of ketamine therapy
• Advanced mental health interventions

The book offers insights into cutting-edge therapies and their potential to revolutionize mental health care, drawing from Walker's extensive experience as a practitioner and subject matter expert.

Revitalist Lifestyle and Wellness Ltd. (RVLWF) announces a joint-venture partnership with GCM Partners, LLC, enabling access to five new locations in Chicago, Orlando, and Miami. This expansion enhances the company's ability to provide ketamine therapy services to patients across the U.S. The agreement includes licensing and managed services for medical and behavioral clinics, increasing Revitalist's telemedicine capabilities.

The joint-venture allows Revitalist to offer comprehensive mental health management solutions, including protocols for discontinuing antidepressants and other medications. Revitalist operates multiple locations and virtual services, reaching over 200 million Americans across 33 states.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) announced a non-brokered private placement to issue up to 85,000,000 units at $0.02 per unit, generating gross proceeds of $1,700,000. Each unit consists of one common share and one purchase warrant, exercisable at $0.05 for two years. The offering may close in multiple tranches and proceeds will support company operations and working capital. All securities are subject to a four-month hold period. Revitalist is a leader in the psychedelic wellness space with a presence across 28 states.